Victor von Kries

Victor von Kries serves as the Director of Mergers & Acquisitions at ADVANZ PHARMA, a position held since January 2023, with responsibilities focused on the origination and execution of global drug acquisitions and regional licensing transactions under the ownership of Nordic Capital. Prior to this role, Victor von Kries was a Manager in Mergers & Acquisitions at Bayer from March 2020 to December 2022, where the focus included executing acquisitions and divestments across pharmaceutical and consumer health sectors. Earlier experience includes working at Credit Suisse as an Investment Banking Associate and Analyst from July 2014 to January 2020, covering sell-side and buy-side M&A transactions and corporate financing in Switzerland. Academic qualifications consist of a Master of Arts in Banking and Finance from Universität St.Gallen and a Bachelor of Science in Business Administration from WHU – Otto Beisheim School of Management, alongside a semester abroad at Hong Kong University of Science & Technology.